Live Online Training: Validation of Analytical Test Procedures & Measurement Uncertainty

Live Online Training: Validation of Analytical Test Procedures & Measurement Uncertainty

Course No 18531

All times mentioned are CET.

Costs

There is no recording available for this Online Training. Are you interested in participating in an upcoming date of this Live Online Training? Would you like to get individual advice on our training portfolio? Contact us.

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Dr Christopher Burgess, Burgess Analytical Consultancy, UK
Trevor J. Coomber, Pharmaceutical Development Consultant, UK
Dr Xaver Schratt, GBA Pharma GmbH, Germany

Objectives

The objectives of this Live Online Training are
  • to offer practical solutions for determining the Validation characteristics
  • to learn how to deal with measurement uncertainty and to understand its impact on analytical methods Validation
  • to understand the qualification of laboratory Equipment as a precondition of reliable analytical testing
  • to discuss the scope of qualification & validation necessary to obtain approval by the Registration Authorities (EMA, FDA, MHRA, etc.)
  • to become familiar with the statistical parameters to be applied
  • to outline the documentation (SOPs, Validation Protocols and Reports, etc.) which you should have in your lab.
  • to provide an outline of the new USP & ICH developments of procedure validation

Background

The current ICH guideline Q2(R1) lists all characteristics to be considered during validation and describes the method of determining the various validation characteristics. Reliable analytical results do not only require validated test procedures but also the use of analytical equipment qualified for its intended purpose. In order to obtain regulatory approval, the qualification of all critical laboratory equipment must be performed and documented ensuring “fitness for purpose”. Furthermore, measurement uncertainty is of key importance in analytical instruments qualification as well as in analytical methods validation and transfer. Therefore it is absolutely essential that measurement uncertainty is well understood by everybody who is responsible for generating and evaluating analytical results in GMP controlled laboratories. In addition there are major revisions planned for both ICH Q2 and a new Q14 on Analytical Procedure Development.

Target Group

This Live Online Training will be of particular interest to Laboratory Managers, Supervisors and Analysts in pharmaceutical quality control departments who have responsibility for the validation of analytical test procedures. Furthermore, this Course is designed for personnel from Quality Assurance, Regulatory Affairs and Contract Laboratories.

Technical Requirements

For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings. At http://www.webex.com/testmeeting. html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.

Programme

Programme Monday, 23 November 2020

Welcome and Introduction

Validation in Context
  • Practical components of data quality
  • Assessment of data quality
  • Analytical Procedure Lifecycle Management; the future direction
  • Course road map
Basics of Measurement Uncertainty
  • Why is measurement uncertainty important?
  • Relationship between uncertainty and confidence
  • Uncertainty of measurement
  • What is a measurand
  • Error sources in analysis and testing
Analytical Instrument Qualification
  • USP <1058> Guidance
  • USP revision process and GAMP
  • Validation Master Plan
  • Definition of DQ, IQ, OQ and PQ
  • Examples of protocols and documents
  • Change Control
  • Risk assessment
Measurement Uncertainty in Calibration and Qualification of Analytical Instruments
  • Qualification, Calibration & Validation
  • Measurement uncertainty
  • Propagation of Errors
  • Measurement uncertainty of a CRM
  • Detection and quantitation Limits
  • Noise & drift
  • Statistical aspects
Q&A Session

Target Measurement Uncertainty
  • Uncertainty and Confidence
  • True Value
  • Combined Standard Uncertainty
  • „Correct Reporting“
  • Decision Rule
Statistical Aspects of Analytical Methods Validation
  • The use (and misuse?) of statistics to support validation data
  • Basic theory of the common statistical techniques
  • Merits, pitfalls and underlying assumptions of particular tests
  • The meaning behind
    • Standard deviation - F-test - t-test
    • ANOVA
    • Linear regression; Correlation Coefficient & Coefficient of Determination
  • Exploration of more sophisticated statistical techniques such as interval hypothesis testing and experimental design
Programme Tuesday, 24 November 2020
 
Q&A Session
 
Robustness and Rugedness: the Pathway to System Suitability Tests
  • Method development cycle
  • Analytical process capability
  • Selecting factors and Levels
  • HPLC experimental design example
  • Impact on system suitability tests
Method Validation During the Development Lifeycle
  • Product Development Life Cycle
  • Sources of Guidance
  • ICH Q14 Concept paper
  • Screening and Early Safety Studies
  • Phase 1 Volunteer Studies
  • Phase 2 Clinical trials
  • Towards MAA/NDA
Q&A Session

Validation for MAA/NDA: Planning and Execution
  • Analytical validation according to ICH Q2(R1) ƒ
  • FDA Guidances and USP proposals for method validation
Validation for MAA/NDA: Documentation
  • Validation protocol / report ƒ
  • Validation documentation for registration ƒ
  • Validation software ƒ
  • Discussion of real validation documentation
Transfer of Analytical Test Procedures
  • Statistical Tests
  • Analytical significance vs statistical significance
  • Acceptance criteria Setting
  • Interval hypotheses
Analytical Procedure Lifecycle Management; the future direction
  • Validation; the changing regulatory climate
  • FDA Process Validation Paradigm shift
  • Analytical Procedure Lifecycle Management
  • Data governance in a regulated laboratory
  • ICH Q12
  • USP <1220>
  • ECA APLM guideline
Q&A Session

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK